MENU
FHTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Foghorn Therapeutics (FHTX) Earnings Date & Reports

Foghorn Therapeutics Inc is engaged in the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system... Show more

A.I. Advisor
published Earnings

FHTX is expected to report earnings to rise 30.61% to -36 cents per share on November 11

Foghorn Therapeutics FHTX Stock Earnings Reports
Q3'25
Est.
$-0.37
Q2'25
Beat
by $0.07
Q1'25
Missed
by $0.11
Q4'24
Beat
by $0.12
Q3'24
Beat
by $0.12
The last earnings report on August 05 showed earnings per share of -28 cents, beating the estimate of -35 cents. With 17.46K shares outstanding, the current market capitalization sits at 290.85M.
View a ticker or compare two or three
FHTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. FHTX showed earnings on August 05, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
500 Technology Square
Phone
+1 617 586-3100
Employees
116
Web
https://www.foghorntx.com